Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program

Abstract Background The Centers for Disease Control and Prevention contracted with laboratories to sequence the SARS-CoV-2 genome from positive samples across the United States to enable public health officials to investigate the impact of variants on disease severity as well as the effectiveness of...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Chirayu Goswami, Michael Sheldon, Christian Bixby, Mehdi Keddache, Alexander Bogdanowicz, Yihe Wang, Jonathan Schultz, Jessica McDevitt, James LaPorta, Elaine Kwon, Steven Buyske, Dana Garbolino, Glenys Biloholowski, Alex Pastuszak, Mary Storella, Amit Bhalla, Florence Charlier-Rodriguez, Russ Hager, Robin Grimwood, Shareef A. Nahas
פורמט: Artigo
שפה:Inglês
יצא לאור: BMC 2022-04-01
סדרה:BMC Infectious Diseases
נושאים:
COVID-19
SARS-CoV-2
Centers for Disease Control
Next generation sequencing
Reverse transcription polymerase chain reaction
Cycle threshold
גישה מקוונת:https://doi.org/10.1186/s12879-022-07374-7
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים